Clinical Trial: A Study to Evaluate the Safety, Tolerability, PK, and PD Properties of PRX-115 in Adult Volunteers with Elevated Uric Acid Levels
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Gout
Study Type: INTERVENTIONAL
Official Title: A Double-blind, Placebo-controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Properties of PRX-115 in Adult Volunteers with Elevated Uri
Brief Summary:
This is a Phase 1, double-blind, placebo-controlled, single ascending dose study in participants with elevated uric acid levels.This study will be conducted in approximately 64 adult male and female participants in the dose escalation phase.
Read more